ONE NUCLEUS STRENGTHENS BOARD WITH APPOINTMENT OF NEW DIRECTOR

Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024

Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024
A Supportive Membership Offer While You Plan Your Next Step
Being made redundant, or finding yourself between roles for any reason, can be an unsettling time. It can also be an important moment to reconnect with your professional community, explore new opportunities, and invest in your next step.
We are looking for a driven Molecular Biologist to join our dynamic, collaborative group. This role will help us strengthen our technologies and processes for the scalable production of peptides and proteins with non-canonical amino acids in our proprietary recoded strains of E. coli. This platform has broad potential applications in the development and manufacturing of new classes of biotherapeutics and beyond.
We are looking for a driven Analytical Scientist to join our dynamic, collaborative Bioprocessing team. This role will help us strengthen our technologies and processes for the scalable production of peptides and proteins with non-canonical amino acids in our proprietary recoded strains of E. coli. This platform has broad potential applications in the development and manufacturing of new classes of biotherapeutics and beyond. Besides technical process development, the role requires ensuring communication between commercial and scientific teams.
In partnership with The Graham Fulford Charitable Trust, Cambridge Clinical Laboratory is organising a Prostate Cancer Testing Event, hosted at Histon & Impington Royal British Legion Club on Tuesday 24 November 2026.
The event aims to raise awareness of prostate cancer and the importance of early detection, giving local men the opportunity to take a proactive approach to their prostate health.
Men attending will be able to access a PSA blood test alongside the Proclarix® advanced prostate cancer test, at a reduced price of £59.
BioFocus: Driving innovation, inspiring collaboration
BioFocus by Bionow brings together leaders from across industry, academia, healthcare and the wider life sciences ecosystem for a day of insight, discussion and meaningful networking.
Launched on Monday, the new Vernalis website offers a fresh outlook and clear message of what Vernalis can deliver on behalf of its pharma and biotech partners.
Vernalis has been a long-standing name in the UK life sciences industry; but this new website emphasises what the company has evolved to become - a specialist HitID and integrated drug discovery service provider with the expertise and capabilities to take a small molecule target through to candidate selection. Please contact Vernalis via the website to find out more.
Antibodies are among the most valuable assets in any biopharma portfolio, and the patents protecting them are often fiercely contested. Securing patents that survive examination, opposition and litigation in Europe requires a clear understanding of the standards applied by the European Patent Office (EPO) and the courts.